CN101797364B - Marzulene-s-containing combined medicine - Google Patents
Marzulene-s-containing combined medicine Download PDFInfo
- Publication number
- CN101797364B CN101797364B CN2010101487577A CN201010148757A CN101797364B CN 101797364 B CN101797364 B CN 101797364B CN 2010101487577 A CN2010101487577 A CN 2010101487577A CN 201010148757 A CN201010148757 A CN 201010148757A CN 101797364 B CN101797364 B CN 101797364B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- medicine
- chinese medicine
- treatment
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 11
- 238000011282 treatment Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 7
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 6
- 201000005917 gastric ulcer Diseases 0.000 claims description 6
- FPKFWYUHWUOPGP-RJXKWAGSSA-M sodium;(2s)-2,5-diamino-5-oxopentanoic acid;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].OC(=O)[C@@H](N)CCC(N)=O.CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 FPKFWYUHWUOPGP-RJXKWAGSSA-M 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241000218176 Corydalis Species 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 241001127714 Amomum Species 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 210000003038 endothelium Anatomy 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 239000002131 composite material Substances 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 5
- 208000012895 Gastric disease Diseases 0.000 description 4
- 208000008469 Peptic Ulcer Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 208000011906 peptic ulcer disease Diseases 0.000 description 4
- 208000018556 stomach disease Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Marzulene-s and traditional Chinese medicine extracts-containing synergetic medicinal composite, and the application of the composite in preparing a medicine for curing the gastrohelcoma.
Description
The present invention relates to a kind of medicine for the treatment of gastropathy, is the compositions of being made by Chinese crude drug extract and Western medicine, is particularly suitable for the medicine as treatment gastritis, peptic ulcer gastropathy such as (containing gastric ulcer and duodenal bulbar ulcer).
Gastropathy, particularly gastritis (shallow harmony in the exterior atrophic), peptic ulcer (containing gastric ulcer and duodenal bulbar ulcer) is a kind of commonly encountered diseases, frequently-occurring disease.At present, the medicine for the treatment of these diseases is more, the curative effect of the degree of having nothing in common with each other, but generally speaking, curative effect is not ideal enough, and relapse rate is higher after the drug withdrawal, and with regard to better medicine at present commonly used: its effective percentage is below 80%, and its relapse rate is more than 36%.
Purpose of the present invention just is: invent a kind of composition medicine of being made up of Chinese medicine extract and Western medicine for the treatment of gastropathy, to improve the treatment curative effect and to reduce relapse rate.
The present invention realizes its purpose like this: the present composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, % counts with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20.
The summation of its each component is 100%.
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and the medicine village is concocted with conventional concocting method, powder is defended in pulverizing, decoct with water, and filtration, concentrated filtrate is to thick paste, drying.
Pharmaceutical composition Chinese medicine and western medicine of the present invention in addition is a Marzulene-S, and the weight ratio of Chinese medicine extract and Western medicine is 67: 1.
Chinese medicine extract prescription in the pharmaceutical composition of the present invention is from the embodiment 1 of CN1055015C.
Pharmaceutical composition of the present invention can be made into various peroral dosage forms, and three times on the one, each 2 grams, seriously ill person's four times a day, boiled water is taken after mixing it with water.For gastritis (shallow table or atrophic), 7 is a course of treatment, serve on 2-3 the course of treatment, and for peptic ulcer (containing gastric ulcer and bulboduodenal ulcer), be a course of treatment January, serve on 2-3 the course of treatment.Taboo: dry peppery, the raw food food such as hard of fasting.
Clinical effectiveness:
To peptic ulcer (containing gastric ulcer and duodenal bulbar ulcer) 42 examples, treat 5 courses of treatment after.Through hospital's fiber microscopy and biopsy, 19 examples of wherein fully recovering, effective 20 examples, invalid 3 examples.Average total effective rate is 92.9%, and the toxic side effect reaction is found at the end.And with the pure Chinese medicine extract or the Marzulene-S of Isodose, effective percentage is respectively 68% and 84%.
The treatment standard declaration: recovery from illness refers to after 2-3 the course of treatment 1 clinical symptom disappearance.Through fiber microscopy and biopsy, foci disappearance.Effectively refer to after 2～8 courses of treatment, through fiber microscopy and biopsy, clinical symptom disappearance, the lesion tissue scope is dwindled.Invalid finger is after 2-3 the course of treatment, and clinical symptoms does not have significant change before fiber microscopy and biopsy and treatment.
Pharmacology and resultant effect analysis.The Rhizoma Curcumae heat-clearing and toxic substances removing of this medicine with the same usefulness of Rhizoma Coptidis, strengthens heat-clearing toxin-expelling functions, Corium elephatis granulation promoting good medicine, and dried Alumen is held back skin ulcer, reuses poliosis, the same usefulness of three flavors, granulation promoting power is grand, and it is remarkable to hold back skin ulcer, promotes the lesion tissue reparation effectively, and well can end digestive tract hemorrhage preferably; Semen Trichosanthis a surname spleen helps circulation of qi promoting intestinal stasis relieving class efficacy of drugs such as Radix Et Rhizoma Nardostachyos more remarkable, has effectively promoted the recovery of gastric motility function, reuses Rhizoma Corydalis, Radix Aristolochiae, fast and effeciently pain relieving.Therefore, comprehensive compatibility, this Chinese patent medicine is heat-clearing and toxic substances removing effectively, and effectively gastric acid inhibitory secretion of Marzulene-S.The Chinese medicine and western medicine binding energy fundamentally reaches therapeutic purposes.
Claims (2)
1. compositions for the treatment of gastric ulcer, said composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, % counts with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20,
The summation of its each component is 100%,
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and medical material is concocted with conventional concocting method, be ground into powder, decoct with water, filtration, concentrated filtrate is to thick paste, drying;
Western medicine is a Marzulene-S, and the weight ratio of Chinese medicine extract and Western medicine is 67: 1.
2. the purposes of compositions as claimed in claim 1 in the medicine of preparation treatment gastric ulcer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101487577A CN101797364B (en) | 2010-04-15 | 2010-04-15 | Marzulene-s-containing combined medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101487577A CN101797364B (en) | 2010-04-15 | 2010-04-15 | Marzulene-s-containing combined medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101797364A CN101797364A (en) | 2010-08-11 |
| CN101797364B true CN101797364B (en) | 2011-06-15 |
Family
ID=42593305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101487577A Expired - Fee Related CN101797364B (en) | 2010-04-15 | 2010-04-15 | Marzulene-s-containing combined medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101797364B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178111A (en) * | 1997-10-21 | 1998-04-08 | 肖启美 | Weijisan for gastropathy |
| CN101066434A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Omeprazole-containing medicine |
| CN101066435A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Iprazole containing medicine |
| CN101269200A (en) * | 2008-04-29 | 2008-09-24 | 乐亚 | Chinese-western medicine composition containing carafate for treating gastric ulcer |
-
2010
- 2010-04-15 CN CN2010101487577A patent/CN101797364B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178111A (en) * | 1997-10-21 | 1998-04-08 | 肖启美 | Weijisan for gastropathy |
| CN101066434A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Omeprazole-containing medicine |
| CN101066435A (en) * | 2007-06-05 | 2007-11-07 | 陈旭龙 | Iprazole containing medicine |
| CN101269200A (en) * | 2008-04-29 | 2008-09-24 | 乐亚 | Chinese-western medicine composition containing carafate for treating gastric ulcer |
Non-Patent Citations (3)
| Title |
|---|
| 刘志杰.《胃粘膜保护与麦滋林-S》.《安徽医药》.1998,第2卷(第1期),3-5. * |
| 杨大平.《消化性溃疡的中西医辨证》.《2006年消化系病学术年会暨胰腺疾病专题讲座论文汇编》.2006,10-14. * |
| 陈治水.《溃疡性结肠炎中西医结合研究新进展》.《第二十一届全国中西医结合学会消化系统疾病学术会议》.2009,37-46. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101797364A (en) | 2010-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066434B (en) | Omeprazole-containing medicine | |
| CN100584371C (en) | Chinese-western medicine composition containing carafate for treating gastric ulcer | |
| CN100515484C (en) | Iprazole containing medicine | |
| CN100534516C (en) | Medicine containing rabeprazole for treating gastric ulcer | |
| CN100515485C (en) | Medicine composition for treating gastric ulcer | |
| CN100574793C (en) | The medicine that contains ranitidine | |
| CN101926958B (en) | Chinese and Western medicine composition containing carbenoxolone sodium | |
| CN1055015C (en) | Weijisan for gastropathy | |
| CN101066418B (en) | Medicine containing colloidal bismuth for treating gastric uncer | |
| CN101850044A (en) | Medicament for treating peptic ulcer and reflux esophagitis and preparation method thereof | |
| CN101797364B (en) | Marzulene-s-containing combined medicine | |
| CN101797356B (en) | Traditional Chinese medicine and Western medicine composition containing Lafutidine | |
| CN101773646B (en) | Chinese and Western medicine composition containing proglumide | |
| CN101732664B (en) | Enprostil-containing Chinese and Western medicinal composition for treating gastric ulcer | |
| CN101797358B (en) | Medicinal composition containing roxatidine | |
| CN101797359B (en) | Chinese and western medicinal composition containing pantoprazole | |
| CN101773645B (en) | Chinese-western medicine composition containing spizofurone | |
| CN101797357B (en) | Chinese-western medicinal composition containing lansoprazole | |
| CN101732663B (en) | Rebamipide-containing Chinese and western medicinal composition | |
| CN101721657B (en) | Chinese and western medicine composition containing licorzinc | |
| CN101810828B (en) | Combination medicament containing teprenone | |
| CN103356942B (en) | Medicine for treating chronic gastritis, gastric ulcer and/or duodenal ulcer and preparation method thereof | |
| CN104258033A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis at acute stage | |
| CN102600287B (en) | Compound medicine for treating toothache | |
| CN103405681B (en) | Preparation method of lozenge for treating oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YE XIYOU Free format text: FORMER OWNER: ZHANG DAYU Effective date: 20110422 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ye Xiyou Inventor before: Zhang Dayu |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100070 BUILDING 18, AREA 8, HEADQUARTERS BASE, NO. 188, SOUTH 4TH RING ROAD WEST, FENGTAI DISTRICT, BEIJING TO: 315100 ROOM 704, NO. 100, CHUNJIANG HUACHENG, 677, SIMING EAST ROAD, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHANG DAYU TO: YE XIYOU |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110422 Address after: Yinzhou District Siming road 315100 Zhejiang city in Ningbo province 677 Spring City No. 704 room 100 Applicant after: Ye Xiyou Address before: 100070, No. 18, building eight, 188, base station, South Fourth Ring Road West, Beijing, Fengtai District Applicant before: Zhang Dayu |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG HUAKE INTELLECTUAL PROPERTY SERVICE CO., L Free format text: FORMER OWNER: YE XIYOU Effective date: 20121217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315100 NINGBO, ZHEJIANG PROVINCE TO: 226600 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121217 Address after: 226600 No. 8 Yingbin Road, Chengdong Town, Haian County, Nantong, Jiangsu Patentee after: Nantong Huake Intellectual Property Service Co.,Ltd. Address before: Yinzhou District Siming road 315100 Zhejiang city in Ningbo province 677 Spring City No. 704 room 100 Patentee before: Ye Xiyou |
|
| ASS | Succession or assignment of patent right |
Owner name: HAIAN CHANGDA TECHNOLOGY TRANSFER CENTER CO., LTD. Free format text: FORMER OWNER: NANTONG HUAKE INTELLECTUAL PROPERTY SERVICE CO., LTD. Effective date: 20140709 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 226600 NANTONG, JIANGSU PROVINCE TO: 226601 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140709 Address after: 226601 No. 8 Yingbin Road, Chengdong Town, Haian County, Nantong, Jiangsu Patentee after: HAIAN CHANGZHOU UNIVERSITY TECHNOLOGY TRANSFER CENTER Co.,Ltd. Address before: 226600 No. 8 Yingbin Road, Chengdong Town, Haian County, Nantong, Jiangsu Patentee before: Nantong Huake Intellectual Property Service Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20221229 Address after: Room 610, Building 3, Science and Technology Mansion, Linyi Hi tech Industrial Development Zone, Shandong Province, 276000 Patentee after: Linyi Enke Development and Construction Co.,Ltd. Address before: 226601 No.8 Yingbin Road, Chengdong Town, Hai'an County, Nantong City, Jiangsu Province Patentee before: HAIAN CHANGZHOU UNIVERSITY TECHNOLOGY TRANSFER CENTER Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110615 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |